Hapella Oy strengthens it’s organization
WellO2 breathing exercise device, developed and marketed by Hapella Oy, has received a great reception and customer feedback on Finnish markets. The company is now launching its international sales and strengthens its recourses with new recruitments. Mr. Kalle Hakala starts on 1.5.2018 as Hapella’s CEO. He has extensive experience in business development, and domestic and international trade, as well as company management. The company’s former CEO, FT Ilpo Kuronen, will be responsible for the company’s research and product development, and clinical research programs.
“With these changes and additional resources, the company creates the prerequisites for strengthening the WellO2 brand, and for further development and international growth,” says Aulis Kärkkäinen, inventor of the WellO2 device and chairman of the board.